GWAS



Map with number of samples per country


DATA BASE

GENOTYPING

GR@ace

Barcelone, Spain

Genomic Research
Applied to Alzheimer’s
Disease

Visit website

GERAD

Cardiff, United Kingdom

Genetic and Environmental
Risk in Alzheimer’s Disease
Consortium.

Visit website

EADI

Lille, France

European Alzheimer
Disease Initiative

DEMGENE

Oslo, Norway

The Norwegian
DemGene Network

DEGESCO

Spain

Dementia Genetic
Spanish Consortium

Visit website

COLLABORATION ON GENOTYPING

EADB believes it is essential to encourage collaboration to improve our knowledge of Alzheimer’s disease and related disorders. The EADB and its partners welcome all types of collaborations on genetics and biomarkers.
Please do not hesitate to contact us


SEQUENCING

SEQUENCING

EADB through its ADES component comprises whole exome sequencing data from 5 countries. All sequencing data have been harmonized using a unique QC and calling pipeline (Holstege et al, Nat Genet, 2022).

We have available whole exome sequencing for 7,376 AD cases and 4,318 controls

12,000 whole genome sequencing are in preparation


BIOMARKERS

Biomarkers

More than 20,000 plasma samples and 10,000 CSF samples may be available through the EADB in the various participating centres.
In addition, the EADB database is regularly enriched by the quantification of numerous biomarkers, depending on the ancillary projects developed as part of the consortium